@tramdungchantomo: Phần 3: Sự thật dinh dưỡng về các loài cá #tramdungchantomo #khampha #khamphathegioi #kienthuc #tiktoknews

Gemwin Trạm dừng chân tò mò
Gemwin Trạm dừng chân tò mò
Open In TikTok:
Region: VN
Friday 18 September 2026 16:04:11 GMT
167798
7875
140
1018

Music

Download

Comments

quannhoduidoltoto
Quán nhỏ du idol toto :
cá saba nó thường bị bỏ qua không phải vì ng ta k biết nó nhiều dinh dưỡng, mà đơn giản vì chế biến món ngon nó khó.
2026-09-19 02:59:16
188
binsua1
Bảo Khánh3416 :
cá thu đao ra chợ dân sinh có ko mấy bác
2026-09-19 04:54:53
0
wolfmen520
Sói :
nhưng ngày nay con người đâu ăn chỉ vì chất dinh dưỡng mà ăn vì ngon.n😌
2026-09-18 22:36:17
49
bzzzzbzzz
bzkkppq :
cá hồi là cú lừa
2026-09-19 11:23:07
16
satthu0baogiongu
Có 1 0 2 $ :
những thứ cơ bản chúng ta ăn đó là kinh nghiệm nhiều đời ông bà để lại vừa dễ kiếm vừa rẻ vừa đủ chất
2026-09-19 04:47:43
20
tikitaka2847
Tiki Taka :
trích ngâm dầu ngon vl mà hết thấy trong siêu thị rồi
2026-09-18 23:01:47
25
frorenxia
Bơ :
Người nhật ăn nhiều cá này nè! Trong siêu thị bán có saba file đông na uy đó! T hay mua ăn😁 mà sao vn k có cá tươi nhỉ
2026-09-19 12:39:24
5
givemepuh
* :
ăn xương thì hấp thụ kiểu j
2026-09-19 11:18:20
0
nguyennhuthuy04
NNh Huyy♋ :
cá sapa- thu đao(thu nhật) là 2 loại cá khác nhau nha
2026-09-19 01:38:21
3
trntin518
3h33 :
cá trích hộp hơi nhiều natri, ăn nhiều cái mặt phình ra như suy thận :))
2026-09-18 18:37:56
0
cuu.khanh.cuong.b
Cuu Khanh Cuong B2407363 :
cá trích cá basa
2026-09-18 23:03:15
3
minh3574967257
😊 :
Cá trích nhiều đạm. Ai bị thận hoặc gút k nên ăn
2026-09-19 04:52:46
1
cr71234567162626262
cr7 papa suuuuuuuuuuuuuuuuuuu :
gọi cá trắm bằng cụ
2026-09-19 13:43:09
0
trungiam88
Trung Ngô :
tóm lại hãy ăn cá thu, cá trích, cá mòi, cá cơm, cá hồi. cái nào vừa túi tiền thì ăn
2026-09-19 13:14:37
1
shiroikoibito.201
DAN :
Chỉ cần áp chảo rồi rưới nước tương lên. Quá đã🥰🥰
2026-09-19 03:20:31
0
domixi3636363636
Cao Bằng tiên tôn :
tuy ăn ko ngon bằng cá chép nhưng cx khá bất ngờ đấy =))
2026-09-19 08:16:35
1
badboy_2102
Bad boy :
Nhưng có sợ nó có chất bảo quản ko? Vì nó là đồ hộp mà
2026-09-19 11:42:20
1
thanhvo319
Thanh Vo :
cá này gọi là cá nục hoa. người mệt ăn vào là bệnh luôn đó
2026-09-19 17:22:45
0
smithhuynh
Smith Huynh :
bị gout nên ko ăn cá trích đuoc. buồn.
2026-09-19 05:38:12
0
vungtauscene
Vũng Tàu :
Cái này ko phải cá saba nhé dịch tầm bậy
2026-09-19 09:50:31
1
aomongxavoi
Ảo Mộng :
Có clip thì bảo cá saba, có clip thì bảo cá thu. Chả hiểu
2026-09-19 01:58:26
1
smithhuynh
Smith Huynh :
tôi mê cá saba lắm mà bị gout ko ăn duoc
2026-09-19 05:39:02
0
nguyenhieu2k00
Nguyễn Hiếu :
Cá trích Nướng , chiến rán lên cuộn với lá cải cay chuấm nước mắm chua ngọt nó đỉnh . Nhưng nhiều xương thì xay ra làm chả cá . Mà các thu đao ( saba ) đắt chứ đâu rẻ .Cá này cực ngon và ít xương . Kho kiểu nhật hoặc nướng thì đỉnh lắm
2026-09-19 03:46:37
3
xiaooying5201314
小樱樱呀ᰔ ᩚ Vicky🍀导游 美容店 :
Cá thu
2026-09-19 00:29:11
1
nguyn.nguyn6376
Nguyễn Nguyên :
Cá nục hoa
2026-09-19 18:22:00
0
To see more videos from user @tramdungchantomo, please go to the Tikwm homepage.

Other Videos

Big news in the world of Obesity Medicine and weight management today, and I want to make sure you actually understand what it means, not just that it happened. The FDA just approved Foundayo (orforglipron), Eli Lilly's once-daily GLP-1 pill for obesity, and it's worth paying attention to. Here's what you need to know: The clinical data: In the Phase 3 ATTAIN trials, patients lost an average of 12.4% of their body weight at the highest dose over 72 weeks. Real, meaningful weight loss. Less than Zepbound's ~21%, but this isn't a shot. It's a pill. The access piece: With commercial insurance, eligible patients could pay as little as $25/month. Self-pay starts at $149. Medicare Part D coverage could begin as early as July at $50/month. For a category where people have been paying $1,000+/month, that matters enormously. The practical difference: Unlike the Wegovy pill, which requires an empty stomach and a 30-minute wait, Foundayo can be taken any time, no food or water restrictions. Side effects: Same GI profile as the rest of this class. The thyroid cancer warning is there too, so if you have a history of medullary thyroid carcinoma, this isn't for you. Is it a replacement for the injectables? No. A legitimate option for people who want oral medication, or an oral maintenance strategy after hitting goal weight? Yes. I sat down one on one with Dave Ricks, CEO of Eli Lilly. That interview is coming, and I think it'll change how you think about where this whole category is headed. Stay close.   Note: I have not been compensated in any way for this post/interview.  #Foundayo #newGLP-1 #GLP-1pill #EliLilly
Big news in the world of Obesity Medicine and weight management today, and I want to make sure you actually understand what it means, not just that it happened. The FDA just approved Foundayo (orforglipron), Eli Lilly's once-daily GLP-1 pill for obesity, and it's worth paying attention to. Here's what you need to know: The clinical data: In the Phase 3 ATTAIN trials, patients lost an average of 12.4% of their body weight at the highest dose over 72 weeks. Real, meaningful weight loss. Less than Zepbound's ~21%, but this isn't a shot. It's a pill. The access piece: With commercial insurance, eligible patients could pay as little as $25/month. Self-pay starts at $149. Medicare Part D coverage could begin as early as July at $50/month. For a category where people have been paying $1,000+/month, that matters enormously. The practical difference: Unlike the Wegovy pill, which requires an empty stomach and a 30-minute wait, Foundayo can be taken any time, no food or water restrictions. Side effects: Same GI profile as the rest of this class. The thyroid cancer warning is there too, so if you have a history of medullary thyroid carcinoma, this isn't for you. Is it a replacement for the injectables? No. A legitimate option for people who want oral medication, or an oral maintenance strategy after hitting goal weight? Yes. I sat down one on one with Dave Ricks, CEO of Eli Lilly. That interview is coming, and I think it'll change how you think about where this whole category is headed. Stay close. Note: I have not been compensated in any way for this post/interview. #Foundayo #newGLP-1 #GLP-1pill #EliLilly

About